D
The Texas implementation of medication algorithms update for bipolar I disorder recommends lamotrigine with or without an antimanic (depending on the
Background Lamotrigine is approved as a maintenance therapy for bipolar I disorder in many countries, including China in 2021
Evidence from randomised, controlled trials suggests lamotrigine is effective in reducing the risk of depressive relapse in stabilised bipolar patients
Folic acid may reduce the efficacy of
Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of
First line/classic treatments for acute bipolar depression
Following remission of a bipolar mood episode, nearly all patients require maintenance treatment to delay or prevent another episode
Women with bipolar I disorder are at very high risk for postpartum mania and psychosis
"Spotlight on lamotrigine in bipolar disorder" next: FAQ: Topiramate (Topamax) for Treating Mood Disorders and
A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
As in BD-I, the aim of maintenance therapy should be to prevent recurrence of the disorder, to cure sub-threshold symptoms and to increase quality of life
Bipolar disorder (BD) is an episodic mood disorder characterised by manic/hypomanic and depressive episodes interspersed with periods of euthymia
Myth #2: Lamotrigine does not treat acute episodes of bipolar depression
Background: Bipolar disorder (BD) is a cyclic mood disorder characterised by alternating episodes of mania/hypomania and depression interspersed with euthymic periods
Haven't found anything that i could eat for even over a month with it but have tried abilify, lithium, latuda, ziprasidone and risperidone with it
J Clin Psychiatry
Head-to-head studies are needed comparing quetiapine to the olanzapine-fluoxetine combination
1, 5
However, the evidence base suggests a more limited role for lamotrigine as part of an overall treatment regimen in bipolar disorder
The dosage of lamotrigine is titrated over a 6-week period to 200 mg/day to minimise the incidence of serious rash
In clinical trials of bipolar and other mood disorders, the rate of serious rash was 0
Background: Patients with rapid-cycling bipolar disorder are often treatment refractory